Inicio › Trastorno depresivo mayor › Arkansas › Little Rock
Ensayos clínicos de Trastorno depresivo mayor en Little Rock, AR
14 estudios para Trastorno depresivo mayor buscan participantes en centros de Little Rock y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
ReclutandoFase 3
- Preferred Research Partners, Inc., Little Rock
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
ReclutandoFase 3
- SanRo Clinical Research Group LLC WCG Clinical Network, Bryant · A 15 mi de distancia
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
ReclutandoFase 3
- SanRo Clinical Research Group LLC WCG Clinical Network, Bryant · A 15 mi de distancia
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
ReclutandoFase 3
- Vanda Investigational Site, Little Rock
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
ReclutandoFase 4
- Neurocrine Clinical Site, Bryant · A 15 mi de distancia
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
ReclutandoFase 3
- SanRo Clinical Research Group, Bryant · A 15 mi de distancia
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
ReclutandoFase 2
- Draig Clinical Site, Little Rock
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
ReclutandoFase 2
- Draig Clinical Site, Little Rock
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
ReclutandoFase 3
- Neurocrine Clinical Site, Bryant · A 15 mi de distancia
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
ReclutandoFase 3
- Woodland International Research Group, Little Rock
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
ReclutandoFase 3
- Neurocrine Clinical Site, Little Rock
- Neurocrine Clinical Site, Bryant · A 15 mi de distancia
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
ReclutandoFase 2
- Preferred Research Partners /ID# 279206, Little Rock
- Woodland International Research Group /ID# 277605, Little Rock
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
ReclutandoFase 2
- Pillar Clinical Research, LLC, Little Rock
- Preferred Research Partners, Inc., Little Rock
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
ReclutandoFase 3
- Neurocrine Clinical Site, Little Rock
Ensayos de Trastorno depresivo mayor en otras ciudades
- New York City, NY36 estudios
- Boston, MA31 estudios
- Atlanta, GA25 estudios
- Philadelphia, PA23 estudios
- Orlando, FL19 estudios
- Miami, FL18 estudios
- Chicago, IL17 estudios
- Tampa, FL17 estudios
- San Diego, CA16 estudios
- Houston, TX16 estudios
- Austin, TX13 estudios
- Las Vegas, NV13 estudios
Otros estudios en Little Rock
- Esquizofrenia19 estudios
- Cáncer (todos los tipos)14 estudios
- Leucemia mielógena aguda13 estudios
- Cáncer de pulmón de células no pequeñas13 estudios
- Obesidad11 estudios
- Cáncer de endometrio10 estudios
- Depresión10 estudios
- Diabetes tipo 210 estudios
- Cáncer de pulmón9 estudios
- Enfermedad cardiovascular9 estudios
- Cáncer de vejiga9 estudios
- Fallo cardíaco9 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.